ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SNG Synairgen Plc

4.36
-0.395 (-8.31%)
Last Updated: 08:44:49
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.395 -8.31% 4.36 4.35 4.69 4.75 4.36 4.75 139,295 08:44:49
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.54 9.58M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.76p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.58 million. Synairgen has a price to earnings ratio (PE ratio) of -0.54.

Synairgen Share Discussion Threads

Showing 22051 to 22074 of 99175 messages
Chat Pages: Latest  883  882  881  880  879  878  877  876  875  874  873  872  Older
DateSubjectAuthorDiscuss
17/8/2020
12:39
Scientists optimistic on lasting immunity even after mild Covid-19 infections
Scientists in the US believe there is growing evidence that the human immune system can indeed put up a long-lasting defence to the novel coronavirus.

Citing a study conducted by researchers at the University of Arizona which has yet to be peer-reviewed, among others, The New York Times reported that the findings also held for people had suffered only mild forms of the disease.

The data presented in the studies were a "welcome indication" that the body's immune response will have a "good chance of fending off the coronavirus, faster and more fervently than before, if exposed to it again."

Another researcher from the University of Washington, Marion Pepper, reportedly said: "All the pieces are there to have a totally protective immune response."

On a more cautious note, for the conclusions to be confirmed, proof was needed that people who came across the virus a second time were indeed able to fend it off, Dr. Pepper said.

Nevertheless, the researcher added that the lack of unambiguous evidence thus far that people were being reinfected "helps to explain that".

master rsi
17/8/2020
10:58
They have no stock to create a market. It is stalemate. Most holding not selling until next news, those on the outside not wanting to pay a premium.
stoneme
17/8/2020
10:46
Fest twice ..
the hammer of fest
Chat Pages: Latest  883  882  881  880  879  878  877  876  875  874  873  872  Older

Your Recent History

Delayed Upgrade Clock